Microgenesis Corporation
Gabriela Gutiérrez is a pivotal figure in the field of medical sciences, serving as the Founder of Microgenesis Corporation since December 2019, where innovative tests and services related to microbiota and miRNAs research are developed to enhance human health, notably through the creation of GYNOMA for improving women's fertility and health issues. Simultaneously, Gutiérrez has been the Founder of Inmunogenesis since July 2015, focusing on technology to identify fertility challenges through products like TiME and the collaboration with Pronacera Therapeutics to offer FERT&i, which evaluates the receptivity of the endometrium. Gutiérrez also holds a position as Científico investigador at CONICET since December 2005 and has prior experience in R&D at Halitus Instituto Médico S.A. from March 2008 to March 2014. Educational qualifications include a Doctorado in Ciencias biomédicas from the University of Buenos Aires and a Licenciatura in Ciencias biológicas y biomédicas from Universidad CAECE, complemented by independent researcher training in medical sciences and technology at CONICET.
This person is not in any teams
This person is not in any offices
Microgenesis Corporation
Microgenesis offers a new fertility test and personalized nutritional supplementation that restores the fertility potential of women everywhere. Microgenesis has proven their validity in tough cases – women who have already failed multiple IVF implantations. Now, they are bringing their solution downmarket to OB-GYNs and D2C, operating out of aCLIA lab in Oakland. Microgenesis’ diagnostic detects subclinical inflammation that harms ovarian function and implantation. Their three-month treatment is drug-free and all-natural.